{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:40:40Z","timestamp":1792435240410,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The present systematic review seeks to examine clinical factors potentially associated with endovascular aortic aneurysm repair (EVAR) failure due to type II endoleaks (TIIEL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Source of data<\/jats:title>\n                    <jats:p>Relevant literature was sourced from PubMed, including all studies regarding clinical features possibly linked to TIIEL, written in English. Studies focused on anatomical predictors, case reports, and abstracts were excluded. The literature search used keywords related to clinical characteristics, comorbidities, and demographics common in EVAR patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Areas of agreement<\/jats:title>\n                    <jats:p>EVAR is the preferred treatment for abdominal aortic aneurysms in eligible patients. The most common complication is endoleak (persistent filling of the sac). TIIEL is caused by retrograde blood flow from aortic side branches and is the most frequent complication, occurring in 16%\u201350% of cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Areas of controversy<\/jats:title>\n                    <jats:p>Many studies have explored anatomical predictors of TIIEL, but limited research is available on clinical factors that may contribute to its occurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Growing points<\/jats:title>\n                    <jats:p>Protective factors against TIIEL included statin therapy, salicylate therapy, smoking, ankle\/brachial systolic blood pressure index &amp;lt;0.87, and chronic obstructive pulmonary disease. Conversely, anticoagulation therapy, inflammatory status, and advanced age were associated with an increased risk of TIIEL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Areas timely for developing research<\/jats:title>\n                    <jats:p>Further prospective research is needed to validate the presented association between clinical factors and EVAR failure due to TIIEL, to allow risk stratification and tailored follow-up strategies for selected groups of patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bmb\/ldag035","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:17:59Z","timestamp":1792433879000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical predictors of type II endoleaks after EVAR: a systematic review of risk and protective factors"],"prefix":"10.1093","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4601-7297","authenticated-orcid":false,"given":"Giulia","family":"Colonna","sequence":"first","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, \u201cSapienza\u201d University of Rome , Via di Grottarossa, 1035, 00189 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5171-8581","authenticated-orcid":false,"given":"Chiara","family":"Fasulo","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, \u201cSapienza\u201d University of Rome , Via di Grottarossa, 1035, 00189 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7386-688X","authenticated-orcid":false,"given":"Mario","family":"Antonelli","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, \u201cSapienza\u201d University of Rome , Via di Grottarossa, 1035, 00189 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1295-5299","authenticated-orcid":false,"given":"Anna","family":"Santini","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, \u201cSapienza\u201d University of Rome , Via di Grottarossa, 1035, 00189 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8151-5686","authenticated-orcid":false,"given":"Costanza","family":"Morucci","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, \u201cSapienza\u201d University of Rome , Via di Grottarossa, 1035, 00189 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7305-076X","authenticated-orcid":false,"given":"Ginevra","family":"Mazzetti","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, \u201cSapienza\u201d University of Rome , Via di Grottarossa, 1035, 00189 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3160-5400","authenticated-orcid":false,"given":"Luigi","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, \u201cSapienza\u201d University of Rome , Via di Grottarossa, 1035, 00189 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-9410","authenticated-orcid":false,"given":"Maurizio","family":"Taurino","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant'Andrea Hospital of Rome, Department of Molecular and Clinical Medicine, \u201cSapienza\u201d University of Rome , Via di Grottarossa, 1035, 00189 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1312-1915","authenticated-orcid":false,"given":"Pasqualino","family":"Sirignano","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Unit, Sant\u2019Andrea Hospital of Rome, Department of General and Specialistic Surgery, \u201cSapienza\u201d University of Rome , Piazzale Aldo Moro, 5, 00185 Roma RM, Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"2026101914175033400_ref1","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/S0140-6736(16)31135-7","article-title":"Endovascular versus open repair of abdominal aortic aneurysm in 15-years\u2019 follow-up of the EVAR trial 1","volume":"388","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"2026101914175033400_ref2","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa1715955","article-title":"Open versus endovascular repair of abdominal aortic aneurysm","volume":"380","author":"Lederle","year":"2019","journal-title":"N Engl J Med"},{"key":"2026101914175033400_ref3","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3390\/diagnostics15212807","article-title":"Neutrophil-to-lymphocyte ratio as marker of outcome after standard EVAR","volume":"15","author":"Toncelli","year":"2025","journal-title":"Diagnostics"},{"key":"2026101914175033400_ref4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.crad.2014.09.010","article-title":"EVAR follow-up imaging: assessment and treatment of postoperative complications","volume":"70","author":"Ilyas","year":"2015","journal-title":"Clin Radiol"},{"key":"2026101914175033400_ref5","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/bjs.9181","article-title":"Type II endoleak after endovascular aneurysm repair","volume":"100","author":"Sidloff","year":"2013","journal-title":"Br J Surg"},{"key":"2026101914175033400_ref6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.tvir.2005.06.001","article-title":"Endoleak: treatment options","volume":"8","author":"Golzarian","year":"2005","journal-title":"Tech Vasc Interv Radiol"},{"key":"2026101914175033400_ref7","doi-asserted-by":"crossref","first-page":"30339","DOI":"10.3390\/jpm12030339","article-title":"Incidence and fate of refractory type II endoleak after EVAR","volume":"12","author":"Sirignano","year":"2022","journal-title":"J Pers Med"},{"key":"2026101914175033400_ref8","doi-asserted-by":"crossref","first-page":"e0170600","DOI":"10.1371\/journal.pone.0170600","article-title":"Prevalence and risk factors of type II endoleaks after EVAR: Meta-analysis","volume":"12","author":"Guo","year":"2017","journal-title":"PloS One"},{"key":"2026101914175033400_ref9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.avsg.2018.09.009","article-title":"Type II endoleak incidence and fate after EVAR with different devices","volume":"56","author":"Sirignano","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"2026101914175033400_ref10","first-page":"370","article-title":"Type II endoleak management","volume":"37","author":"Chen","year":"2020","journal-title":"Semin Intervent Radiol"},{"key":"2026101914175033400_ref11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejvs.2023.11.002","article-title":"ESVS 2024 guidelines on abdominal aorto-iliac aneurysms","volume":"67","author":"Wanhainen","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026101914175033400_ref12","first-page":"354","article-title":"Italian society guidelines on AAA management","volume":"63","author":"Pratesi","year":"2022","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2026101914175033400_ref13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.asjsur.2022.03.022","article-title":"Predictive factors for type II endoleak","volume":"46","author":"Su\u00e1rez Gonz\u00e1lez","year":"2023","journal-title":"Asian J Surg"},{"key":"2026101914175033400_ref14","doi-asserted-by":"crossref","first-page":"ivac016","DOI":"10.1093\/icvts\/ivac016","article-title":"IMA diameter and lumbar arteries as predictors of type II endoleak","volume":"35","author":"Kondov","year":"2022","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2026101914175033400_ref15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejvs.2003.10.016","article-title":"Is a type II endoleak after EVAR a harbinger of risk? Causes and outcome of open conversion and aneurysm rupture during follow-up","volume":"27","author":"Van Marrewijk","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026101914175033400_ref16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jvs.2010.02.290","article-title":"Effect of warfarin on endoleak development after EVAR","volume":"52","author":"Bobadilla","year":"2010","journal-title":"J Vasc Surg"},{"key":"2026101914175033400_ref17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jvs.2011.12.018","article-title":"The influence of smoking on endovascular abdominal aortic aneurysm repair","volume":"55","author":"Koole","year":"2012","journal-title":"J Vasc Surg"},{"key":"2026101914175033400_ref18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1583\/13-4462R.1","article-title":"Warfarin treatment and EVAR durability: Meta-analysis","volume":"21","author":"Lazarides","year":"2014","journal-title":"J Endovasc Ther"},{"key":"2026101914175033400_ref19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejvs.2013.12.009","article-title":"Safety of chronic anticoagulation after EVAR","volume":"47","author":"De Rango","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026101914175033400_ref20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.avsg.2015.03.036","article-title":"Influence of statins on type II endoleak evolution","volume":"29","author":"Pini","year":"2015","journal-title":"Ann Vasc Surg"},{"key":"2026101914175033400_ref21","first-page":"69","article-title":"Characteristics of type II endoleak in east Asian patients","volume":"80","author":"Fujimura","year":"2015","journal-title":"Circ J"},{"key":"2026101914175033400_ref22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jvs.2016.11.032","article-title":"Antiplatelet therapy and sac expansion in type II endoleaks","volume":"66","author":"\u00c1lvarez Marcos","year":"2017","journal-title":"J Vasc Surg"},{"key":"2026101914175033400_ref23","doi-asserted-by":"crossref","first-page":"e0170600","DOI":"10.1371\/journal.pone.0170600","article-title":"Prevalence and risk factors of type II endoleaks after endovascular aneurysm repair: a meta-analysis","volume":"12","author":"Guo","year":"2017","journal-title":"PloS One"},{"key":"2026101914175033400_ref24","first-page":"624","article-title":"Influence of warfarin on postoperative endoleaks after EVAR","volume":"24","author":"Seike","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2026101914175033400_ref25","first-page":"484","article-title":"PET\/CT predicts and detects complications after EVAR","volume":"26","author":"Courtois","year":"2019","journal-title":"J Endovasc Ther"},{"key":"2026101914175033400_ref26","first-page":"27356","article-title":"Nomogram to predict reintervention for type II endoleak after EVAR","volume":"13","author":"Liu","year":"2023","journal-title":"Sci Rep"},{"key":"2026101914175033400_ref27","first-page":"1164","article-title":"Fate of endoleaks and impact of anticoagulation","volume":"74","author":"Flohr","year":"2021","journal-title":"J Vasc Surg"},{"key":"2026101914175033400_ref28","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jvs.2021.06.341","article-title":"Anticoagulation is associated with type II endoleaks after EVAR","volume":"74","author":"Kong","year":"2021","journal-title":"J Vasc Surg"},{"key":"2026101914175033400_ref29","first-page":"107405","article-title":"Remodeling of AAA sac after EVAR: clinical and genetic factors","volume":"58","author":"D\u2019Oria","year":"2022","journal-title":"Cardiovasc Pathol"},{"key":"2026101914175033400_ref30","doi-asserted-by":"crossref","DOI":"10.1177\/15266028231214761","article-title":"Effect of anticoagulation on EVAR outcomes: systematic review","volume":"32","author":"Kontopodis","year":"2025","journal-title":"J Endovasc Ther"},{"key":"2026101914175033400_ref31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/15266028231158302","article-title":"Identifying patients at high risk for post-EVAR aneurysm sac growth","volume":"31","author":"Bruijn","year":"2024","journal-title":"J Endovasc Ther"},{"key":"2026101914175033400_ref32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1583\/10-3116.1","article-title":"Predictive factors for the development of type II endoleaks","volume":"18","author":"Marchiori","year":"2011","journal-title":"J Endovasc Ther"},{"key":"2026101914175033400_ref33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.avsg.2015.03.036","article-title":"Influence of statin therapy on type 2 endoleak evolution","volume":"29","author":"Pini","year":"2015","journal-title":"Ann Vasc Surg"},{"key":"2026101914175033400_ref34","first-page":"1","article-title":"European guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"40","author":"Perk","year":"2012","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2026101914175033400_ref35","doi-asserted-by":"crossref","DOI":"10.1007\/s00392-025-02764-8","article-title":"AAA progression: review of preclinical and clinical data","volume":"115","author":"Schahab","year":"2026","journal-title":"Clin Res Cardiol"},{"key":"2026101914175033400_ref36","doi-asserted-by":"crossref","first-page":"e0329500","DOI":"10.1371\/journal.pone.0329500","article-title":"Risk factors for AAA in general populations: Meta-analysis","volume":"20","author":"Zhang","year":"2025","journal-title":"PloS One"}],"container-title":["British Medical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bmb\/article-pdf\/160\/1\/ldag035\/72115696\/ldag035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bmb\/article-pdf\/160\/1\/ldag035\/72115696\/ldag035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:18:05Z","timestamp":1792433885000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bmb\/article\/doi\/10.1093\/bmb\/ldag035\/8943646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/bmb\/ldag035","relation":{},"ISSN":["0007-1420","1471-8391"],"issn-type":[{"value":"0007-1420","type":"print"},{"value":"1471-8391","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,12]]},"published":{"date-parts":[[2026,10,5]]},"article-number":"ldag035"}}